Ketotifen treatment of active colitis in patients with 5-aminosalicylate intolerance

Canadian Journal of Gastroenterology

Volumn 12, Issue 4, 1998, Pages 273-275

  Marshall, John K ^a,b   Irvine, E Jan ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

Aminosalicylate allergy; Collagenous colitis; Crohn's disease; Ketotifen; Mast cells; Ulcerative colitis

Indexed keywords

CORTICOSTEROID; KETOTIFEN; MESALAZINE; PREDNISONE; SALAZOSULFAPYRIDINE;

ADULT; AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; COLLAGENOUS COLITIS; CROHN DISEASE; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; MAST CELL; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; ULCERATIVE COLITIS;

EID: 0031841290     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/1998/398142     Document Type: Article

References (15)

1. Nakajima S, Krishnan B, Ota H, et al. Mast cell involvement in gastritis with or without Helicobacter pylori infection. Gastroenterology 1997;113:746-54.
2. Karmeli F, Eliakim R, Okon E, Rachmilewitz D. Gastric mucosal damage by ethanol is mediated by substance P and prevented by ketotifen, a mast cell stabilizer. Gastroenterology 1991;100:1206-16.
3. Araki Y, Kakegawa T, Stadil F. Mast cells and histamine release in Crohn's disease. Kurume Med J 1993;40:93-9.
4. Deren JJ, Bai C, Sohn M, et al. Accumulation of mast cells and proteinases in the bowel wall in Crohn's disease but not ulcerative colitis. Gastroenterology 1996;110:A893. (Abst)
5. Fox CC, Lazenby AJ, Moore WC, Yardley JH, Bayless TM, Lichenstein LM. Enhancement of human intestinal mast cell mediator release in active ulcerative colitis. Gastroenterology 1990;99:119-24.
6. Eliakim R, Karmeli F, Okon E, Rachmilewitz D. Ketotifen ameliorates capsaicin-augmented acetic acid-induced colitis. Dig Dis Sci 1995;40:503-9.
7. Pothoulakis C, Karmeli F, Kelly CP, et al. Ketotifen inhibits Clostridium difficile toxin A induced enteritis in rat ileum. Gastroenterology 1993;105:701-7.
8. Hoshino M, Nakamura Y, Shin Z, Fukushima Y. Effects of ketotifen on symptoms and on bronchial mucosa in patients with atopic asthma. Allergy 1997;52:814-20.
9. Eliakim R, Karmeli F, Chorev M, Okon E, Rachmilewitz D. Effect of drugs on colonic eicosanoid accumulation in active ulcerative colitis. Scand J Gastroenterol 1992;27:968-72.
10. Heyman SN, Karmeli F, Brezis M, Rachmilewitz D. The effect of ketotifen on nitric oxide synthase activity. Br J Pharmacol 1997;120:1545-51.
11. Abu-Dalu R, Zhang J, Hanani M. The actions of ketotifen on intestinal smooth muscles. Eur J Pharmacol 1996;309:189-93.
12. Martinolle JP, Garcia-Villar R, More J, Bueno L. Evidence for mast cell, leukotriene and nitric oxide involvement in the regulation of the adrenoreceptor number of inflamed small intestine in guinea pigs. Neurogastroenterol Motil 1995;7:187-95.
13. Patterson R, Fitzsimons EJ, Choy AC, Harris KE. Malignant and corticosteroid-dependent idiopathic anaphylaxis: successful responses to ketotifen. Ann Allergy Asthma Immunol 1997;79:138-44.
14. Bitton A, Peppercorn MA, Hanrahan JP, Upton MP. Mesalazine-induced lung toxicity. Am J Gastroenterol 1996;91:1039-40.
15. Hautekeete ML, Bourgeois N, Potvin P. Hypersensitivity with hepatotoxicity to mesalazine after hypersensitivity to sulfasalazine. Gastroenterology 1992;103:1925-7.